
$NBIS (CMP $83) - Deep Dive Investment Thesis with Bull, Bear & Base case price scenarios! 🧵 Nebius is building the picks & shovels for the AI revolution. After a brutal 30% drawdown, the risk/reward has never been more compelling. Here’s why this could be a generational opportunity: 1/ THE SETUP •Current: $83 •Analyst avg target: $157 (88% upside) •Bull target: $211 (153% upside) •5 Buy ratings, 0 Sells •Recent 30% drop created entry point 2/ THE OPPORTUNITY AI infrastructure is the most supply-constrained market in tech. Hyperscalers spending $405B in 2025, projected $500B+ in 2026. GPU compute is gold, and NBIS is positioned as THE third-party provider. 3/ REVENUE TRAJECTORY •Q3 2025: $146M (+355% YoY) •2025E: $500-550M •2026 target: $7-9B ARR •That’s 1,300-1,600% growth potential over 12 months 4/ CONTRACT BACKLOG •$3B Meta deal (deploying Dec ’25) •$17.4B Microsoft Azure agreement •2.5 GW contracted power, 1 GW connecting by end 2026 •Customer diversification = reduced risk 5/ THE BULL CASE (PT: $250-300) ✅ Hits $6B+ revenue in 2026 ✅ GAAP EPS: $6+ ✅ Captures 3-5% of AI infra market ✅ Profitability ahead of schedule ✅ Stock re-rates to 40-50x forward earnings 6/ THE BASE CASE (PT: $140-170) → $4.5-5B revenue in 2026 → GAAP EPS: $4-5 → Minor delays but solid execution → Trades at 30-35x forward earnings → Meets analyst consensus 7/ THE BEAR CASE (PT: $50-70) ❌ Only $3-4B revenue (execution issues) ❌ Power constraints delay capacity ❌ AI spending slowdown ❌ Dilutive capital raises (25-35%) ❌ FCF burn accelerates to -$8-9B 8/ KEY RISKS •Burning $658M FCF currently •CapEx raised from $2B to $5B •P/E: 97x (stretched valuation) •Power constraints & supply chain issues •Profitability timeline uncertain 9/ WHY NOW? 1.Stock down 30% despite $3B Meta deal 2.Testing technical support at $82-83 3.Oversold conditions (WR signal) 4.No analyst downgrades post-earnings 5.2026 is THE inflection year 10/ THE VERDICT This is a binary bet on AI infrastructure scaling. If NBIS executes, $200+ is realistic by late 2026. If they stumble, $50s possible. Risk/Reward: 3:1 upside/downside Time horizon: 12-18 months Position sizing: 2-5% max (although my size is closer to 40% of my portfolio) 11/ MY TAKE At $83, the market is pricing in significant execution risk. But with $20B+ in contracts and analysts maintaining Buy ratings, the setup favors patient capital. Not financial advice. DYOR. 📊
















